Laboratory Corp. Of America Holdings Earnings

Laboratory Corp. Of America Holdings’s revenue jumped 5.3% since last year same period to $3345.1Mn in the Q1 2025. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated 0.47% jump in its revenue since last 3-months.

Laboratory Corp. Of America Holdings’s net profit fell -6.67% since last year same period to $212.8Mn in the Q1 2025. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated 48.4% jump in its net profits since last 3-months.

Laboratory Corp. Of America Holdings’s net profit margin fell -11.37% since last year same period to 6.36% in the Q1 2025. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated 47.7% jump in its net profit margins since last 3-months.

Laboratory Corp. Of America Holdings’s price-to-earnings ratio after this Q1 2025 earnings stands at 28.82.

Laboratory Corp. Of America Holdings’s earning per share (EPS) estimates for the current quarter stand at 4.07 - a -2.63% fall from last quarter’s estimates.

Laboratory Corp. Of America Holdings’s earning per share (EPS) estimates for the current year stand at 4.07.

Laboratory Corp. Of America Holdings’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Laboratory Corp. Of America Holdings has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Laboratory Corp. Of America Holdings declared 0.72 dividend per share during the earnings announcement for Q3 2025.